Human decidual NK cells: Unique and tightly regulated effector functions in healthy and pathogen-infected pregnancies

Frontiers in Immunology

Volumn 4, Issue NOV, 2013, Pages

  Le Bouteiller, Philippe ^a  

^a France   (France)

Author keywords

Angiogenic factors; Cytokine; Cytomegalovirus; Cytotoxicity; decidual NK cell; Pathogens; Pregnancy

Indexed keywords

EID: 84890397735     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00404     Document Type: Article

References (56)

1. Manaster I, Mandelboim O. The unique properties of human NK cells in the uterine mucosa. Placenta (2008) 29(Suppl A):S60-6. doi: 10.1016/j.placenta.2007.10.006
2. Koopman L, Kopcow H, Rybalov B, Boyson J, Orange J, Schatz F, et al. Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J Exp Med (2003) 198:1201-12. doi:10.1084/jem.20030305
3. Bulmer JN, Williams PJ, Lash GE. Immune cells in the placental bed. Int J Dev Biol (2010) 54:281-94. doi:10.1387/ijdb.082763jb
4. Moffett-King A. Natural killer cells and pregnancy. Nat Rev Immunol (2002) 2:656-63. doi:10.1038/nri886
5. Tabiasco J, Rabot M, Aguerre-Girr M, El Costa H, Berrebi A, Parant O, et al. Human decidual NK cells: unique phenotype and functional properties-a review. Placenta (2006) 27(Suppl A):S34-9. doi:10.1016/j.placenta.2006.01.009
6. Le Bouteiller P, Tabiasco J, Polgar B, Kozma N, Giustiniani J, Siewiera J, et al. CD160: a unique activating NK cell receptor. Immunol Lett (2011) 138:170-5. doi:10.1016/j.imlet.2011.02.003
7. Le Bouteiller P, Barakonyi A, Giustiniani J, Lenfant F, Marie-Cardine A, Aguerre-Girr M, et al. Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity. Proc Natl Acad Sci U S A (2002) 99:16963-8. doi:10.1073/pnas.012681099
8. Male V, Sharkey A, Masters L, Kennedy PR, Farrell LE, Moffett A. The effect of pregnancy on uterine NK cell KIR repertoire. Eur J Immunol (2011) 41:1-11. doi:10.1002/eji.201141445
9. Vacca P, Mingari M, Moretta L. Natural killer cells in human pregnancy. J Reprod Immunol (2013) 97:14-9. doi:10.1016/j.jri.2012.10.008
10. Erlebacher A. Immunology of the maternal-fetal interface. Annu Rev Immunol (2013) 31:387-411. doi:10.1146/annurev-immunol-032712-100003
11. Quenby S, Nik H, Innes B, Lash G, Turner M, Drury J, et al. Uterine natural killer cells and angiogenesis in recurrent reproductive failure. Hum Reprod (2009) 24:45-54. doi:10.1093/humrep/den348
12. Vacca P, Moretta L, Moretta A, Mingari MC. Origin, phenotype and function of human natural killer cells in pregnancy. Trends Immunol (2011) 32:517-23. doi:10.1016/j.it.2011.06.013
13. Kalkunte SS, Mselle TF, Norris WE, Wira CR, Sentman CL, Sharma S. Vascular endothelial growth factor C facilitates immune tolerance and endovascular activity of human uterine NK cells at the maternal-fetal interface. J Immunol (2009) 182:4085-92. doi:10.4049/jimmunol.0803769
14. Croy BA, Esadeg S, Chantakru S, van den Heuvel M, Paffaro VA, He H, et al. Update on pathways regulating the activation of uterine natural killer cells, their interactions with decidual spiral arteries and homing of their precursors to the uterus. J Reprod Immunol (2003) 59:175-91. doi:10.1016/S0165-0378(03)00046-9
15. Cerdeira AS, Rajakumar A, Royle C, Lo A, Husain Z, Thadhani RI, et al. Conversion of peripheral blood NK cells to a decidual NK-like phenotype by a cocktail of defined factors. J Immunol (2013) 190:3939-48. doi:10.4049/jimmunol.1202582
16. Siewiera J, El Costa H, Tabiasco J, Berrebi A, Cartron G, Le Bouteiller P, et al. Human cytomegalovirus infection elicits new decidual natural killer cell effector function. PLoS Pathog (2013) 9:e1003257. doi:10.1371/journal.ppat.1003257
17. Hanna J, Goldman-Wohl D, Hamani Y, Avraham I, Greenfield C, Natanson-Yaron S, et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med (2006) 12:1065-74. doi:10.1038/nm1452
18. Lash GE, Robson SC, Bulmer JN. Review: functional role of uterine natural killer (uNK) cells in human early pregnancy decidua. Placenta (2010) 31(Suppl):S87-92. doi:10.1016/j.placenta.2009.12.022
19. Lippe EMO, Yamada AT, Sharma S. Human uterine natural killer cell: friends or foes of pregnancy outcome. In: Chaouat G, Sandra O, Lédée N editors. Immunology of Pregnancy 2013. Sharjah: Bentham Science Publishers (2013). p. 360-76.
20. Lash GE, Schiessl B, Kirkley M, Innes BA, Cooper A, Searle RF, et al. Expression of angiogenic growth factors by uterine natural killer cells during early pregnancy. J Leukoc Biol (2006) 80:572-80. doi:10.1189/jlb.0406250
21. Rajagopalan S, Bryceson YT, Kuppusamy SP, Geraghty DE, van der Meer A, Joosten I, et al. Activation of NK cells by an endocytosed receptor for soluble HLA-G. PLoS Biol (2006) 4:e9. doi:10.1371/journal.pbio.0040009
22. El Costa H, Casemayou A, Aguerre-Girr M, Rabot M, Berrebi A, Parant O, et al. Critical and differential roles of NKp46-and NKp30-activating receptors expressed by uterine NK cells in early pregnancy. J Immunol (2008) 181:3009-17.
23. Le Bouteiller P, Solier C, Pröll J, Aguerre-Girr M, Fournel S, Lenfant F. Placental HLA-G protein expression in vivo: where and what for? Hum Reprod Update (1999) 5:223-33. doi:10.1093/humupd/5.3.223
24. Rajagopalan S, Long EO. Cellular senescence induced by CD158d reprograms natural killer cells to promote vascular remodeling. Proc Natl Acad Sci U S A (2012) 109:20596-601. doi:10.1073/pnas.1208248109
25. Pijnenborg R. Manipulating human reproduction: a retrospective view on Aldous Huxley's Brave New World. Gynecol Obstet Invest (2006) 61:149-54. doi:10.1159/000090627
26. Madeja Z, Yadi H, Apps R, Boulenouar S, Roper SJ, Gardner L, et al. From the cover: paternal MHC expression on mouse trophoblast affects uterine vascularization and fetal growth. Proc Natl Acad Sci U S A (2011) 108:4012-7. doi:10.1073/pnas.1005342108
27. Croy BA, Chantakru S, Esadeg S, Ashkar AA, Wei Q. Decidual natural killer cells: key regulators of placental development (a review). J Reprod Immunol (2002) 57:151-68. doi:10.1016/S0165-0378(02)00005-0
28. Lima PDA, Paffaro VA Jr, Yamada AT. Functional duality of mouse uterine natural killer cell in pregnancy. In: Chaouat G, Sandra O, Lédée N editors. Immunology of Pregnancy 2013. Sharjah: Bentham Science Publishers (2013). p. 335-58.
29. Xiong S, Sharkey AM, Kennedy PR, Gardner L, Farrell LE, Chazara O, et al. Maternal uterine NK cell-activating receptor KIR2DS1 enhances placentation. J Clin Invest (2013) 123:4264-72. doi:10.1172/JCI68991
30. El Costa H, Tabiasco J, Berrebi A, Parant O, Aguerre-Girr M, Piccinni MP, et al. Effector functions of human decidual NK cells in healthy early pregnancy are dependent on the specific engagement of natural cytotoxicity receptors. J Reprod Immunol (2009) 82:142-7. doi:10.1016/j.jri.2009.06.123
31. Salazar-Mather TP, Hamilton TA, Biron CA. A chemokine-to-cytokine-to-chemokine cascade critical in antiviral defense. J Clin Invest (2000) 105:985-93. doi:10.1172/JCI9232
32. Jost S, Altfeld M. Control of human viral infections by natural killer cells. Annu Rev Immunol (2013) 31:163-94. doi:10.1146/annurev-immunol-032712-100001
33. Kopcow HD, Allan DS, Chen X, Rybalov B, Andzelm MM, Ge B, et al. Human decidual NK cells form immature activating synapses and are not cytotoxic. Proc Natl Acad Sci U S A (2005) 102:15563-8. doi:10.1073/pnas.0507835102
34. Veljkovic Vujaklija D, Dominovic M, Gulic T, Mahmutefendic H, Haller H, Saito S, et al. Granulysin expression and the interplay of granulysin and perforin at the maternal-fetal interface. J Reprod Immunol (2013) 97:186-96. doi:10.1016/j.jri.2012.11.003
35. Yadi H, Burke S, Madeja Z, Hemberger M, Moffett A, Colucci F. Unique receptor repertoire in mouse uterine NK cells. J Immunol (2008) 181:6140-7.
36. Koch J, Steinle A, Watzl C, Mandelboim O. Activating natural cytotoxicity receptors of natural killer cells in cancer and infection. Trends Immunol (2013) 34:182-91. doi:10.1016/j.it.2013.01.003
37. Gazit R, Gruda R, Elboim M, Arnon TI, Katz G, Achdout H. Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat Immunol (2006) 7:517-23. doi:10.1038/ni1322
38. Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, et al. Innate or adaptive immunity? The example of natural killer cells. Science (2011) 331:44-9. doi:10.1126/science.1198687
39. Vacca P, Pietra G, Falco M, Romeo E, Bottino C, Bellora F, et al. Analysis of natural killer cells isolated from human decidua: evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK-cell function. Blood (2006) 108:4078-85. doi:10.1182/blood-2006-04-017343
40. Le Bouteiller P. MHC antigen expression/function at the embryonic interface. Part A: major histocompatibility complex class I unique expression in human trophoblast: facts, questions and controversies. In: Chaouat G, Sandra O, Lédée N editors. Immunology of Pregnancy 2013. Sharjah: Bentham Science Publishers (2013). p. 158-73.
41. Favier B, Lemaoult J, Lesport E, Carosella ED. ILT2/HLA-G interaction impairs NK-cell functions through the inhibition of the late but not the early events of the NK-cell activating synapse. FASEB J (2010) 24:689-99. doi:10.1096/fj.09-135194
42. Navarro F, Llano M, Bellon T, Colonna M, Geraghty DE, Lopez-Botet M. The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur J Immunol (1999) 29:277-83. doi:10.1002/(SICI)1521-4141(199901)29:01<277::AID-IMMU277>3.0.CO;2-4
43. Marlin R, Nugeyre MT, Duriez M, Cannou C, Le Breton A, Berkane N, et al. Decidual soluble factors participate in the control of HIV-1 infection at the maternofetal interface. Retrovirology (2011) 8:58. doi:10.1186/1742-4690-8-58
44. Hurtado CW, Golden-Mason L, Brocato M, Krull M, Narkewicz MR, Rosen HR, et al. Innate immune function in placenta and cord blood of hepatitis C-seropositive mother-infant dyads. PLoS One (2010) 5:e12232. doi:10.1371/journal.pone.0012232
45. Nigro G, Piazze J, Paesano R, Mango T, Provvedi S, Capuano O, et al. Low levels of natural killer cells in pregnant women transmitting Toxoplasma gondii. Prenat Diagn (1999) 19:401-4. doi:10.1002/(SICI)1097-0223(199905)19:5<401::AID-PD559>3.0.CO;2-X
46. Sartelet H, Schleiermacher D, Le-Hesran JY, Graesslin O, Gaillard D, Fe M, et al. Less HLA-G expression in Plasmodium falciparum-infected third trimester placentas is associated with more natural killer cells. Placenta (2005) 26:505-11. doi:10.1016/j.placenta.2004.08.006
47. Riley JK. Trophoblast immune receptors in maternal-fetal tolerance. Immunol Invest (2008) 37:395-426. doi:10.1080/08820130802206066
48. Moffett A, Loke C. Immunology of placentation in eutherian mammals. Nat Rev Immunol (2006) 6:584-94. doi:10.1038/nri1897
49. Pereira L, Maidji E, McDonagh S, Tabata T. Insights into viral transmission at the uterine-placental interface. Trends Microbiol (2005) 13:164-74. doi:10.1016/j.tim.2005.02.009
50. Prins J, Gomez-Lopez N, Robertson S. Interleukin-6 in pregnancy and gestational disorder. J Reprod Immunol (2012) 95:1-14. doi:10.1016/j.jri.2012.05.004
51. Quillay H, Marlin R, Duriez M, Nugeyre MT, Menu E. The control of HIV-1 in utero transmission at the materno-fetal interface by immunological determinants. In: Chaouat G, Sandra O, Lédée N editors. Immunology of Pregnancy 2013. Sharjah: Bentham Science Publishers (2013). p. 827-55.
52. Crncic TB, Laskarin G, Frankovic KJ, Tokmadzic VS, Strbo N, Bedenicki I, et al. Early pregnancy decidual lymphocytes beside perforin use Fas ligand (FasL) mediated cytotoxicity. J Reprod Immunol (2007) 73:108-17. doi:10.1016/j.jri.2006.07.001
53. Xu X, Fu Q, Zhang Q, Zhao M, Gao Z, Liu X, et al. Changes of human decidual natural killer cells cocultured with YFP-Toxoplasma gondii: implications for abnormal pregnancy. Fertil Steril (2013) 99:427-32. doi:10.1016/j.fertnstert.2012.09.016
54. Muntasell A, Ópez-Montañés ML, Vera A, Heredia G, Romo N, Peñafiel J, et al. NKG2C zygosity influences CD94/NKG2C receptor function and the NK-cell compartment redistribution in response to human cytomegalovirus. Eur J Immunol (2013). doi:10.1002/eji.201343773. [Epub ahead of print].
55. Fang M, Orr MT, Spee P, Egebjerg T, Lanier LL, Sigal LJ. CD94 is essential for NK cell-mediated resistance to a lethal viral disease. Immunity (2011) 34:579-89. doi:10.1016/j.immuni.2011.02.015
56. Scott-Algara D, Arnold V, Didier C, Kattan T, Pirozzi G, Barre-Sinoussi F, et al. The CD85j+ NK cell subset potently controls HIV-1 replication in autologous dendritic cells. PLoS One (2008) 3:e1975. doi:10.1371/journal.pone.0001975